Lisa A Polin Selected Research

Neoplasm Metastasis (Metastasis)

1/2014	Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis.
1/2013	CARP-1 functional mimetics: a novel class of small molecule inhibitors of medulloblastoma cell growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa A Polin Research Topics

Disease

13	Neoplasms (Cancer) 07/2020 - 02/2006
3	Triple Negative Breast Neoplasms 01/2020 - 01/2017
2	Glioma (Gliomas) 07/2020 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 07/2020 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2014 - 01/2013
1	Breast Neoplasms (Breast Cancer) 12/2018
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2017
1	Fanconi Anemia (Fanconi's Anemia) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Triploidy 07/2015
1	Disease Progression 07/2015
1	Meningioma (Meningiomas) 07/2015
1	Alcoholism (Alcohol Abuse) 01/2014
1	Malignant Mesothelioma 01/2014
1	Mesothelioma 01/2012

Drug/Important Bio-Agent (IBA)

2	Pharmaceutical PreparationsIBA 07/2020 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2017
2	tocophersolanIBA 11/2018 - 12/2017
2	KynurenineIBA 01/2017 - 01/2016
2	Tryptophan (L-Tryptophan)FDA Link 01/2017 - 01/2016
2	VimentinIBA 07/2015 - 01/2014
2	Metalloproteases (Metalloproteinases)IBA 01/2014 - 01/2013
1	Omeprazole (Prilosec)FDA LinkGeneric 07/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 07/2020
1	Proton Pump InhibitorsIBA 07/2020
1	CytokinesIBA 01/2020
1	Coloring Agents (Dyes)IBA 11/2018
1	Everolimus FDA Link 11/2018
1	Caspase 3 (Caspase-3)IBA 11/2018
1	rociletinibIBA 07/2018
1	Sorafenib (BAY 43-9006)FDA Link 07/2018
1	Tyrosine Kinase InhibitorsIBA 07/2018
1	LipidsIBA 07/2018
1	ErbB Receptors (EGF Receptor)IBA 07/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2017
1	PlatinumIBA 01/2017
1	Progesterone FDA LinkGeneric 01/2017
1	InterleukinsIBA 01/2017
1	blocking factorIBA 01/2017
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 01/2016
1	Kynurenine 3-Monooxygenase (Kynurenine 3 Monooxygenase)IBA 01/2016
1	EnzymesIBA 01/2016
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2016
1	kynureninaseIBA 01/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2015
1	Disulfiram (Antabuse)FDA Link 01/2014
1	CopperIBA 01/2014
1	Aldehyde DehydrogenaseIBA 01/2014
1	GTP-Binding Proteins (G-Protein)IBA 01/2013
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2012
1	withaferin AIBA 01/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2008
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 02/2006
1	CB694IBA 02/2006

Therapy/Procedure

5	Therapeutics 12/2018 - 07/2015
1	Drug Therapy (Chemotherapy) 01/2020
1	Immunotherapy 12/2017
1	Oral Administration 09/2015
1	Transplantation 07/2015
1	Injections 01/2014